Protocol Y

Y) CDI INJECTION Intravenous Chlorine Dioxide (for Physicians only)

● 5 ml of CDS (0.3% = 3000 ppm) per 500 ml of 0.9% NaCl.

This type of treatment is strictly reserved for medical professionals in the investigative health sector. The patient must have signed a prior consent form to comply with the regulations of § 37 of the Helsinki Protocol (AMA).

Protocol Y: 5 ml of CDS (0.3% = 3000 ppm) per 500 ml of 0.9% NaCl. Protocol Y, or the intravenous protocol (Injection), has several methods for using CDI (injectable chlorine dioxide).

CDI = 0.9% NaCl saline solution + chlorine dioxide (preferably electrolytic and microfiltered CDE) in aqueous solution. It is not used intramuscularly. The goal is to achieve sufficient saturation, as CDS is consumed within two hours without leaving measurable residues, decomposing in a short time to common salt and oxygen. Intravenous use is mainly indicated for acute cases of hypoxia, sepsis, and histamine reactions. For chronic diseases, protocols C and E are primarily applied first, and the intravenous route can be used as a stimulus to reach deeper tissue.

A. Subcutaneous use:

A simple way to address local problems is by subcutaneous injection of papules. The protocol consists of injecting several subcutaneous papules with a concentration of 50 ppm (=0.005%) and pH 7.6 in a volume of 2-5 ml of chlorine dioxide solution (CDI) near the affected area. As a gas dissolved in water, it is easily distributed in the affected area. It can be repeated if necessary.

Note: If the pH is below 7.4, a light burning sensation may be experienced. Therefore, it is compensated by tamponade with an 8% bicarbonate solution by adding approximately 1-2 ml to a 0.9% NaCl saline bag. Subsequently, the pH should be checked with a calibrated digital meter.

Tip: If a pH meter is not available, the pH can be checked before injecting by placing a few drops of the CDI (saline with prepared CDS) in the tear duct and blinking slightly. The solution should feel pleasant, like an eye drop. Otherwise, it may be too concentrated or have a low pH.

B. Intravenous use:

1. The patient should have followed an oral or rectal protocol at least 7 days prior to initiating this therapeutic approach (with exceptions in acute cases) for best results and to ensure adequate saturation.
2. Catheterization is performed by placing peripheral lines with a permeable intravenous catheter (~18 or 20 gauge), changing arms at each infusion; the number of infusions is decided according to the patient's condition.
3. Perform the venous puncture gently to avoid hematomas.
4. Optionally and as recommended, pre- and post-venous blood gas analysis can be performed to determine the patient's pH, pCO2, pO2, BEecf, LAC, and CREA to assess the efficacy of the dose.
5. Based on the patient's plasma ionogram, environment, personal history, and clinical history, the use of physiological solution without dextrose is determined according to availability. It is advisable to use isotonic physiological NaCl solution (0.9%) or lactate-free Ringer's solution.
6. Add 1 to 2 ml of concentrated CDS (0.3% = 3000 ppm) per 100 ml of isotonic NaCl (0.9%) saline.
7. The standard dose is determined as 5 ml of Chlorine Dioxide Electrolyte (CDE) at 3000 ppm in 500 ml of saline over a 5-hour period, as needed. The dose may be doubled but should be administered more slowly to avoid burning sensations or phlebitis. In emergency cases, standard CDS can also be used. Electrolyte CDS is simply purer and does not contain traces. For higher doses, the subclavicular route is used.
8. The pH of the infusion bag with the included solutions (CDE + saline solution) should preferably be pH 7.6, digitally measured and calibrated. To correct and reach the indicated pH range in case it is lower, it should be buffered with an 8% bicarbonate solution (HCO3). Typically, 1-2 ml is used for a 500 ml bag of NaCl (0.9%) saline solution. This small amount does not override or neutralize the ClO2 content and avoids irritation or burning of the veins. If a pH meter is not available, the pH can be checked before injecting by placing a few drops of the CDI (saline with prepared CDS) in the eye by blinking slightly. The solution should feel pleasant, like an eye drop. If not, this indicates that it is too concentrated or that the pH is low.
9. The indicated oxygenating hydration with CDI is 500 ml to be administered over a period of 3-6 hours. The contents of the bag should be at room temperature and protected from direct sunlight (UV rays), which would eliminate its effectiveness.
10. A continuous infusion pump (CIP) can be used for a precise and timely drip if necessary for hospitalized patients who require constant infusion due to their severity. It can also be applied subclavicularly without problems.
11. A second venous blood gas analysis can be performed to record post-IV status.
12. Standard duration: 4 consecutive days in severe acute cases or twice a week in chronic cases and always accompanied by Protocol C20.
13. Adequate post-puncture compression is recommended to avoid bleeding.
14. Saturation can be continued with oral and/or rectal CDS two hours after IV application, Protocol C, and/or Protocol E.
15. In critically ill or intubated patients, it can be applied without prior oral dosing with a drip of 30 drops per minute with 10-15 ml of CDI (3000 ppm) in a 500 ml NaCl (0.9%) saline bag adjusted to pH 7.6 but preferably administered slowly over 6-8 hours.
16. In subsequent applications, vary the injection site at different locations to avoid irritation or burning.

C. Surgical Use: For surgical use, various concentrations are employed:

A. To disinfect wounds, prevent adhesions, cancer surgery, and osteomyelitis: A solution with a concentration of 300-400 ppm in NaCl saline (0.9%) is used to disinfect wounds, prevent adhesions, perform cancer surgery, and treat osteomyelitis. This specific concentration has cleansing properties that promote recovery without infection at a rate of 50% faster in such cases. Additionally, its use has been observed to generate no reported toxic effects. An added advantage is its ability to reduce scar formation or adhesions during surgeries. This is especially beneficial since scars can be unsightly and limit functionality in the affected area. By decreasing scar formation, this solution contributes to improved aesthetic appearance and a more complete healing process.

Another important aspect is the role this solution plays in the differentiation and growth of stem cells. By accelerating this vital process in the human body, faster and more efficient recovery is stimulated. This means that patients can experience significant improvement without requiring antibiotics or other medications.

B. To stop non-clotting bleeds: A solution with a concentration between 500 and 1000 parts per million (ppm) can be used for this purpose. An effective method involves applying moderate pressure with a CDS-saturated buffer over the affected area. This approach has the advantage of not forming clots, which avoids possible complications such as infection or sepsis. Additionally, this treatment has been found to accelerate the healing process by stimulating both healing mitosis and the differentiation and activation of stem cells present in the damaged area.

In summary, applying a concentrated solution of CDS in NaCl saline (0.9%) offers multiple benefits in wound treatment and care, rendering traditional methods obsolete in surgery. It does not cause pain upon application and disinfects without damaging cells while maintaining an optimal electromolecular charge, thereby avoiding scarring or necrosis. From its disinfectant capacity to its ability to reduce scarring and accelerate recovery, this solution is highly effective and safe for use in various medical procedures.